Emerging Companies in the Vietnam ADHD Medication Market | Insights & Key Players 2026

Code: MTA12503 Publication Date: May 2026

Emerging Companies in the Vietnam ADHD Medication Market

The Vietnam ADHD Medication Market is rapidly growing, due to longstanding presence of local pharmaceutical giants and global organizations. Some of the key players in the market include Janssen Vietnam, Novartis Vietnam, Takeda Vietnam, and Viatris Vietnam.

Vietnam ADHD Medication Market Overview

According to 6Wresearch, the Vietnam ADHD Medication Market is expected to show a significant growth, owing to the rapidly aging population, along with rising prevalence of metabolic syndromes. The growing occurrence of adult ADHD and paediatric diagnoses increases the demand for a broad range of pharmacological treatments. Additionally, improved healthcare infrastructure and increasing consumer awareness about mental health are driving innovation in advanced therapies, like non-invasive nerve stimulation, and next-generation pain management solutions.

Competitive Landscape

The competitive landscape of the Vietnam ADHD medication industry is driven by biotech investment and strategic global partnerships. The market witnesses a strong competition between global giants and domestic players, that offer a variety of ADHD medications, such as nerve supplements and sophisticated prescription grade anaesthetics.

Below is a list of leading players operating in the Vietnam ADHD Medication Market:

1. Janssen Vietnam

Company NameJanssen Vietnam
Established Year1953 (Global) / 1990s (Vietnam Presence)
HeadquartersBeerse, Belgium (Global) / Ho Chi Minh City, Vietnam
Official WebsiteClick Here

Janssen Vietnam is a dominant leader in the ADHD space, providing Concerta, which is essential for treating ADHD in paediatric and adult patients.

2. Novartis Vietnam

Company NameNovartis Vietnam
Established Year1996 (Merger)
HeadquartersBasel, Switzerland (Global) / Ho Chi Minh City, Vietnam
Official Website-

Novartis Vietnam is a global powerhouse known for its R&D in central nervous system therapies, offering high-quality methylphenidate formulations.

3. Takeda Vietnam

Company NameTakeda Vietnam
Established Year1781 (Global) / 2012 (Representative Office)
HeadquartersTokyo, Japan (Global) / Ho Chi Minh City, Vietnam
Official WebsiteClick Here

Takeda Vietnam maintains a strong presence with its specialized CNS portfolio, focusing on the introduction of long-acting stimulant treatments.

4. Viatris Vietnam

Company NameViatris Vietnam
Established Year2020 (Global/Vietnam Launch)
HeadquartersCanonsburg, USA (Global) / Ho Chi Minh City, Vietnam
Official WebsiteClick Here

Viatris Vietnam contributes to the market with a robust portfolio of neuroprotective agents and specialized generic medications.

5. Savipharm (Sa Gon Pharmaceutical Joint Stock Company)

Company NameSavipharm (Sa Gon Pharmaceutical Joint Stock Company)
Established Year2005
HeadquartersHo Chi Minh City, Vietnam
Official Website-

The Savipharm brand focuses on innovative biological treatments and supportive over-the-counter nerve health solutions that cater to the growing population.

6. GSK Vietnam

Company NameGSK Vietnam
Established Year1715 (Global) / 1994 (Vietnam Presence)
HeadquartersLondon, UK (Global) / Ho Chi Minh City, Vietnam
Official WebsiteClick Here

GSK Vietnam is a leader in CNS research, developing next-generation therapies through strategic alliances with global innovators for neurological and behavioural health.

7. Pfizer Vietnam

Company NamePfizer Vietnam
Established Year1849 (Global) / 1994 (Vietnam Presence)
HeadquartersNew York, USA (Global) / Ho Chi Minh City, Vietnam
Official WebsiteClick Here

Pfizer Vietnam contributes to the market with its established portfolio of metabolic and CNS medications, managing the underlying comorbidities often associated with ADHD.

8. Sanofi Vietnam

Company NameSanofi Vietnam
Established Year1973 (Global) / 1960s (Vietnam Presence)
HeadquartersParis, France (Global) / Ho Chi Minh City, Vietnam
Official WebsiteClick Here

Sanofi Vietnam is highly specialized in neurology, providing localized pharmacological solutions and R&D for neuro-psychiatric treatment advancement.

9. Boehringer Ingelheim Vietnam

Company NameBoehringer Ingelheim Vietnam
Established Year1885 (Global) / 1998 (Vietnam Presence)
HeadquartersIngelheim, Germany (Global) / Ho Chi Minh City, Vietnam
Official Website-

Boehringer Ingelheim Vietnam provides specialized treatments for underlying neurological pathways and continues to invest in pharmaceutical innovation.

10. Pymepharco

Company NamePymepharco
Established Year1989
HeadquartersTuy Hoa, Phu Yen, Vietnam
Official WebsiteClick Here

Pymepharco is a rapidly growing player in the CNS segment, offering cost-effective therapeutic options for patients managing ADHD.

Emerging Companies in the Vietnam ADHD Medication Market: FAQs

The market is dominated by Janssen, Novartis and Takeda, through their prominent brands, such as Concerta and Ritalin, that are frequently used to treat ADHD symptoms.
Domestic producers such as Savipharm and Pymepharco are active in the research of complex generic formulations, along with specialized CNS treatments.
The market is being driven by the rising acceptance of mental health treatment, increased rates of diagnosis, and the growth of private paediatric healthcare services.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All